注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Veru Inc是一家生物制药公司。该公司专注于开发用于治疗急性呼吸窘迫综合征(ARDS)和其他病毒相关ARDS高危住院COVID-19患者以及治疗乳腺癌和前列腺癌的药物。该公司在其性健康计划中提供两种FDA批准的产品,包括用于治疗良性前列腺增生的ENTADFI(他达拉非 5mg 和非那雄胺 5mg 胶囊)和FC2女用避孕套(内部避孕套)(FC2),用于防止意外怀孕的双重保护以及性传播感染的传播。其乳腺癌药物管线有两种药物的四个临床开发项目,例如口服选择性雄激素受体靶向激动剂enobosarm和口服细胞骨架破坏剂sabizabulin。其前列腺癌药物管线包括sabizabulin、VERU-100和zuclomiphene citrate。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Mitchell S. Steiner | 61 | 2016 | Chairman, President & CEO |
Harry Fisch | 63 | 2016 | Vice Chairman & Chief Corporate Officer |
Mario Eisenberger | 74 | 2016 | Independent Director |
Xiaoqin Lu | 49 | 2021 | Independent Director |
Michael L. Rankowitz | 66 | 2018 | Independent Director |
Andrew Sproule Love | 80 | 2013 | Board Observer |
Grace S. Hyun | 52 | 2020 | Independent Director |
Erik Swenson | - | 2023 | Member of the Scientific Advisory Board |
David D. Ho | 71 | 2023 | Chairman of Scientific Advisory Board |
Adrian Sandra Dobs | - | 2024 | Member of Scientific Advisory Board |
Robert T. Schooley | - | 2023 | Member of the Scientific Advisory Board |
William J. Evans | - | 2024 | Member of Scientific Advisory Board |
Shalender Bhasin | - | 2024 | Member of Scientific Advisory Board |
Louis J. Aronne | 68 | 2024 | Chief Medical Advisor & Member of the Scientific Advisory |
Caroline M. Apovian | - | 2024 | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核